Myocarditis is diagnosed through a combination of blood tests, heart imaging, and electrical recordings of the heart, with cardiac MRI serving as the primary confirmatory tool in most cases. No single test can definitively confirm it on its own, so doctors piece together findings from several sources. The process typically starts with simpler screening tests and moves toward more advanced imaging depending on what those initial results show.
Blood Tests: The First Step
When myocarditis is suspected, the first thing drawn is blood. Two types of markers matter most: proteins released by damaged heart muscle, and signs of inflammation throughout the body.
Troponin is the most important blood marker. This protein leaks out of heart cells when they’re injured, and elevated levels are one of the earliest signals that something is wrong. High-sensitivity troponin tests are particularly useful. In one pediatric study, a specific cutoff value provided 100% sensitivity and 95% specificity for detecting myocarditis, meaning it caught virtually every case while rarely producing a false alarm. That said, troponin rises in heart attacks too, which is exactly why further testing is needed to tell the two apart.
C-reactive protein (CRP), a general marker of inflammation, is also drawn early on. A meta-analysis across multiple studies found that CRP levels in myocarditis patients are significantly higher than in controls, with viral myocarditis producing the biggest spikes. CRP alone can’t confirm myocarditis, but when combined with troponin and imaging, it strengthens the picture. It’s also useful for tracking how the inflammation responds to treatment over time.
ECG: Quick but Not Definitive
An electrocardiogram is usually done immediately because it’s fast, cheap, and available in any emergency department. In myocarditis, the ECG can mimic a heart attack, showing ST-segment elevation (the pattern associated with blocked arteries) or the subtler changes seen in other types of cardiac events. The tricky part is that these patterns overlap heavily with actual heart attacks, so an ECG alone can’t distinguish between the two.
A few features nudge suspicion toward myocarditis rather than a heart attack. Patients are typically younger (under 40), often report a recent viral illness, and the ECG changes tend to appear in patterns that don’t match a single blocked artery. Instead of changes in leads that correspond to one blood vessel’s territory, myocarditis tends to produce more widespread or diffuse abnormalities. Still, these are clues rather than proof.
Echocardiogram: Checking Heart Function
A standard echocardiogram (ultrasound of the heart) is performed early to assess how well the heart is pumping and to look for fluid around it. In myocarditis, findings are variable. Some patients show obvious wall motion abnormalities or reduced pumping strength, while others look completely normal on a conventional echo.
That’s a real limitation. Standard ultrasound can miss subtle damage. A more advanced technique called speckle tracking echocardiography measures tiny deformations in heart muscle during each beat. In documented cases, this method has detected reduced strain in specific heart wall segments even when the conventional echo appeared normal and the overall pumping fraction was preserved. Speckle tracking isn’t available everywhere, but when it is, it adds sensitivity that standard echo lacks.
Cardiac MRI: The Key Confirmatory Test
Cardiac MRI is the most important non-invasive test for confirming myocarditis. It can directly visualize both inflammation (swelling) and injury (scarring or cell damage) in the heart muscle, which no other imaging tool does as well.
Diagnosis relies on a standardized framework called the Lake Louise Criteria. The updated version requires two types of abnormal findings. The first is a T2-based criterion, which detects active swelling in the heart muscle through increased water content. The second is a T1-based criterion, which picks up tissue injury through changes in the heart muscle’s properties or through a pattern of scarring visible after contrast dye is injected. Meeting both criteria together provides the strongest diagnostic confidence.
Having just one of these findings (either swelling alone or injury alone) can still support a myocarditis diagnosis if the rest of the clinical picture fits, but with less certainty. Additional supporting evidence on MRI includes signs of pericarditis (inflammation of the sac around the heart) and reduced pumping function.
One of cardiac MRI’s most valuable roles is distinguishing myocarditis from a heart attack. In a heart attack, the pattern of injury follows the territory of a blocked artery and starts from the inner wall of the heart outward. In myocarditis, the injury pattern is different: it tends to appear in the middle or outer layers of the heart wall and doesn’t correspond to any single artery’s distribution. This distinction is often the piece that clinches the diagnosis.
Telling Myocarditis Apart From a Heart Attack
This is one of the biggest diagnostic challenges because the two conditions look almost identical at first. Both cause chest pain, ECG changes, and elevated troponin. Even echocardiograms can show similar wall motion abnormalities in both conditions. In clinical practice, many patients with myocarditis initially undergo evaluation for a suspected heart attack.
When the clinical picture is ambiguous, doctors use coronary angiography (imaging the heart’s arteries) or CT angiography to check whether any arteries are blocked. Clean arteries in a patient with elevated troponin and chest pain strongly suggest myocarditis rather than a heart attack. From there, cardiac MRI confirms the diagnosis by showing the characteristic inflammation pattern described above.
The ratio of CRP to troponin at admission has also shown promise as an early differentiator. Myocarditis tends to produce a disproportionately high CRP relative to the troponin level, while heart attacks typically show the reverse. This ratio isn’t used as a standalone test, but it can help guide the diagnostic workup in the emergency department.
Endomyocardial Biopsy: The Gold Standard for Severe Cases
Taking a small tissue sample directly from the heart muscle remains the definitive way to confirm myocarditis. Under the Dallas criteria, pathologists look for immune cells infiltrating the heart tissue alongside evidence of heart cell damage. The updated version of these criteria sets specific thresholds: at least 14 immune cells per square millimeter and at least 7 T-cells per square millimeter.
Biopsy also allows direct testing for viral genetic material in the tissue. Using PCR analysis, labs can screen for a panel of viruses commonly linked to myocarditis, including adenovirus, enterovirus, cytomegalovirus, parvovirus, Epstein-Barr virus, and influenza A. In a large study of 624 tissue samples from myocarditis patients, viral genetic material was detected in 38% of cases. Notably, blood samples drawn at the same time detected virus in less than 1% of patients, which is why tissue-based testing is far more reliable than blood-based viral screening for identifying the cause.
Despite being the gold standard, biopsy is not routine. It’s an invasive procedure with real risks, so it’s reserved for specific situations: new heart failure with dangerous heart rhythms or hemodynamic instability, or cases that don’t improve with standard treatment within one to two weeks. It may also be considered in patients on medications known to be toxic to the heart or those with autoimmune conditions where confirming the diagnosis would change treatment.
Testing in Children
The diagnostic approach in children follows the same general framework, but with practical differences. Cardiac MRI use in pediatric myocarditis has increased significantly, rising to 37% of cases in recent years, while the use of cardiac catheterization and biopsy has declined during the same period. MRI is now considered confirmatory rather than just suggestive in pediatric diagnosis.
Biopsy is used even less frequently in children than in adults. Many of the standard indications for biopsy were developed based on adult data, and the procedure carries additional challenges in smaller patients. The main obstacles with cardiac MRI in young children are the need for breath-holding (which may require sedation), signal quality limitations in very small bodies, and the requirement for intravenous contrast dye.
Children who develop myocarditis in the setting of multisystem inflammatory syndrome (MIS-C) tend to show notably higher CRP values than children with myocarditis from other causes, along with more variable symptoms. These children also tend to recover heart pumping function more quickly, which can be useful information when interpreting follow-up imaging.